RIPE-KG · Version 1.1.0 · Resource

ripekg:work/10.1016%2Fs1474-4422%2820%2930277-5

https://w3id.org/ripe/ripe-kg/work/10.1016%2Fs1474-4422%2820%2930277-5
SubjectPredicateObject
ripekg:work/10.1016%2Fs1474-4422%2820%2930277-5Cognitive impairment in multiple sclerosis: Clinical management, MRI, and therapeutic avenues prism:doi 10.1016/s1474-4422(20)30277-5
ripekg:work/10.1016%2Fs1474-4422%2820%2930277-5Cognitive impairment in multiple sclerosis: Clinical management, MRI, and therapeutic avenues dcterms:title Cognitive impairment in multiple sclerosis: Clinical management, MRI, and therapeutic avenues
ripekg:work/10.1016%2Fs1474-4422%2820%2930277-5Cognitive impairment in multiple sclerosis: Clinical management, MRI, and therapeutic avenues rdf:type node1
ripekg:work/10.1016%2Fs1474-4422%2820%2930277-5Cognitive impairment in multiple sclerosis: Clinical management, MRI, and therapeutic avenues rdf:type http://purl.org/spar/fabio/Work
ripekg:work/10.1016%2Fs1474-4422%2820%2930277-5Cognitive impairment in multiple sclerosis: Clinical management, MRI, and therapeutic avenues rdf:type rdfs:Resource
ripekg:work/10.1016%2Fs1474-4422%2820%2930277-5Cognitive impairment in multiple sclerosis: Clinical management, MRI, and therapeutic avenues rdf:type owl:Thing
ripekg:work/10.1016%2Fs1474-4422%2820%2930277-5Cognitive impairment in multiple sclerosis: Clinical management, MRI, and therapeutic avenues rdf:type prov:Entity
ripekg:work/10.1016%2Fs1474-4422%2820%2930277-5Cognitive impairment in multiple sclerosis: Clinical management, MRI, and therapeutic avenues rdf:type ripe:WorkWork
ripekg:work/10.1016%2Fs1474-4422%2820%2930277-5Cognitive impairment in multiple sclerosis: Clinical management, MRI, and therapeutic avenues owl:sameAs https://semopenalex.org/work/W3084818633
ripekg:work/10.1177%2F00343552251377422Attitude and Use of Cannabis in People With Multiple Sclerosis: A Scoping Review http://purl.org/spar/cito/cites ripekg:work/10.1016%2Fs1474-4422%2820%2930277-5Cognitive impairment in multiple sclerosis: Clinical management, MRI, and therapeutic avenues